← Leaderboards
Carol A. Clayberger
Stanford University
$7,372,894
Attributed
$7,372,894
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.8M · FY2005–06$2M$1.5M$1M$500K$0
'05
'06
Funding mix
By agency
NIH$7,372,894 · 3
By mechanism
U19$4,878,376 · 1
R01$2,494,518 · 2
Top collaborators
No co-investigators on record.
Most similar at Stanford University
Same institution · by research overlap
- Samuel Strober$36,157,957
- Edgar G. Engleman$35,389,843
- Olivia M Martinez$20,491,021
- Robert S Negrin$29,816,136
- Sheri M. Krams$11,764,466
Others in their field
Top investigators on “Laboratory Mouse”
- Richard K. Wilson · Washington University$122,948,010
- Frank Patrick McCormick · University Of California San Francisco$87,382,096
- David Heimbrook · Leidos Biomedical Research, Inc.$81,904,667
- Kc Kent Lloyd · University Of California At Davis$56,148,943
- Alfred G Gilman · University Of Texas Sw Med Ctr/Dallas$53,869,943
- Carol J Bult · Jackson Laboratory$47,860,052
Research focus
Laboratory MouseImmune Tolerance /UnresponsivenessClinical ResearchPhosphorylationMhc Class Ii AntigenApoptosisMicroorganism ImmunologyInterferon GammaCalcium FluxCell LineBcl2 Gene /ProteinGene Deletion MutationBiological Signal TransductionCytochrome CArtificial ImmunosuppressionImmunosuppressiveGenetic TechniquesHeart TransplantationLaboratory RatInterleukin 12Human TissueMitogen Activated Protein KinaseCell ProliferationPotassium
Grant awards (11)
Granulysin Derived Immunotherapeutics for Biodefense$1,398,061
U19 · FY2006 · AI · contact PI
M Tuberculosis CTL Epitopes: Vaccine Design/Evaluation$390,600
R01 · FY2006 · AI · contact PI
Granulysin Derived Immunotherapeutics for Biodefense$1,393,965
U19 · FY2005 · AI
M Tuberculosis CTL Epitopes: Vaccine Design/Evaluation$400,000
R01 · FY2005 · AI
Granulysin Derived Immunotherapeutics for Biodefense$1,357,159
U19 · FY2004 · AI
M Tuberculosis CTL Epitopes: Vaccine Design/Evaluation$400,000
R01 · FY2004 · AI
HLA Derived Peptides in Transplantation$320,209
R01 · FY2004 · AI
Granulysin Derived Immunotherapeutics for Biodefense$729,191
U19 · FY2003 · AI
M Tuberculosis CTL Epitopes: Vaccine Design/Evaluation$397,083
R01 · FY2003 · AI
HLA Derived Peptides in Transplantation$319,538
R01 · FY2003 · AI
HLA Derived Peptides in Transplantation$267,088
R01 · FY2002 · AI